Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSSD 169 is a selective ATP competitive inhibitor of the MAP kinases p38α (IC50 = 3.2 nM) and p38β (IC50 = 122 nM).1 It has no inhibitory effect against a panel of other kinases, including p38γ MAP kinase, ERK2, JNK-
WARNING This product is not for human or veterinary use.
1. Preventive and therapeutic potential of p38α-
2. Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp. Neurol. 184(2), 606-614 (2003).